Daganatellenes kezelésben részesült gyermekek késoi pulmonalis toxicitásának vizsgálata

Translated title of the contribution: Examination of late pulmonary toxicity in children treated for malignancies

Zsófia Jordán, Zsófia Tokodi, Ágnes Németh, J. Müller, Mónika Csóka, Adrienn Mohl, Dániel Erdélyi, Gábor Kovács

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: The present investigation was based on a survey in 2005, in which the authors found pulmonary function abnormalities in survivors of childhood cancer, who were treated with anticancer therapy. Aim: The purpose of the present study was to follow-up childhood cancer survivors and detect late pulmonary toxicity. Patients and methods: Lung function test was performed with spirometry in 26 survivors participated in this study (10 females and 16 males; mean age, 19.4 years at the time of the second follow-up evaluation). The average time periods from treatment until the first and second follow-up evaluation were 4.5 and 10 years, respectively. Results: The authors found 14 patients with pathological pulmonary function tests results at the time of the first follow-up evaluation, from which 7 patients had obstructive, 5 patients had mixed and 2 patients had restrictive abnormalities. However, there were only 6 patients who had abnormal pulmonary function at the time of the second follow-up evaluation (2 patients with obstructive and 4 patients with restrictive pulmonary function tests (p

Original languageHungarian
Pages (from-to)345-350
Number of pages6
JournalOrvosi Hetilap
Volume154
Issue number9
DOIs
Publication statusPublished - Mar 1 2013

Fingerprint

Lung
Respiratory Function Tests
Neoplasms
Survivors
Spirometry
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Jordán, Z., Tokodi, Z., Németh, Á., Müller, J., Csóka, M., Mohl, A., ... Kovács, G. (2013). Daganatellenes kezelésben részesült gyermekek késoi pulmonalis toxicitásának vizsgálata. Orvosi Hetilap, 154(9), 345-350. https://doi.org/10.1556/OH.2013.29549

Daganatellenes kezelésben részesült gyermekek késoi pulmonalis toxicitásának vizsgálata. / Jordán, Zsófia; Tokodi, Zsófia; Németh, Ágnes; Müller, J.; Csóka, Mónika; Mohl, Adrienn; Erdélyi, Dániel; Kovács, Gábor.

In: Orvosi Hetilap, Vol. 154, No. 9, 01.03.2013, p. 345-350.

Research output: Contribution to journalArticle

Jordán, Z, Tokodi, Z, Németh, Á, Müller, J, Csóka, M, Mohl, A, Erdélyi, D & Kovács, G 2013, 'Daganatellenes kezelésben részesült gyermekek késoi pulmonalis toxicitásának vizsgálata', Orvosi Hetilap, vol. 154, no. 9, pp. 345-350. https://doi.org/10.1556/OH.2013.29549
Jordán, Zsófia ; Tokodi, Zsófia ; Németh, Ágnes ; Müller, J. ; Csóka, Mónika ; Mohl, Adrienn ; Erdélyi, Dániel ; Kovács, Gábor. / Daganatellenes kezelésben részesült gyermekek késoi pulmonalis toxicitásának vizsgálata. In: Orvosi Hetilap. 2013 ; Vol. 154, No. 9. pp. 345-350.
@article{bc64e8cc4f1948c4a0fa69462efc0c17,
title = "Daganatellenes kezel{\'e}sben r{\'e}szes{\"u}lt gyermekek k{\'e}soi pulmonalis toxicit{\'a}s{\'a}nak vizsg{\'a}lata",
abstract = "Introduction: The present investigation was based on a survey in 2005, in which the authors found pulmonary function abnormalities in survivors of childhood cancer, who were treated with anticancer therapy. Aim: The purpose of the present study was to follow-up childhood cancer survivors and detect late pulmonary toxicity. Patients and methods: Lung function test was performed with spirometry in 26 survivors participated in this study (10 females and 16 males; mean age, 19.4 years at the time of the second follow-up evaluation). The average time periods from treatment until the first and second follow-up evaluation were 4.5 and 10 years, respectively. Results: The authors found 14 patients with pathological pulmonary function tests results at the time of the first follow-up evaluation, from which 7 patients had obstructive, 5 patients had mixed and 2 patients had restrictive abnormalities. However, there were only 6 patients who had abnormal pulmonary function at the time of the second follow-up evaluation (2 patients with obstructive and 4 patients with restrictive pulmonary function tests (p",
keywords = "childhood malignancies survivors, lung function test, obstructive changes",
author = "Zs{\'o}fia Jord{\'a}n and Zs{\'o}fia Tokodi and {\'A}gnes N{\'e}meth and J. M{\"u}ller and M{\'o}nika Cs{\'o}ka and Adrienn Mohl and D{\'a}niel Erd{\'e}lyi and G{\'a}bor Kov{\'a}cs",
year = "2013",
month = "3",
day = "1",
doi = "10.1556/OH.2013.29549",
language = "Hungarian",
volume = "154",
pages = "345--350",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "9",

}

TY - JOUR

T1 - Daganatellenes kezelésben részesült gyermekek késoi pulmonalis toxicitásának vizsgálata

AU - Jordán, Zsófia

AU - Tokodi, Zsófia

AU - Németh, Ágnes

AU - Müller, J.

AU - Csóka, Mónika

AU - Mohl, Adrienn

AU - Erdélyi, Dániel

AU - Kovács, Gábor

PY - 2013/3/1

Y1 - 2013/3/1

N2 - Introduction: The present investigation was based on a survey in 2005, in which the authors found pulmonary function abnormalities in survivors of childhood cancer, who were treated with anticancer therapy. Aim: The purpose of the present study was to follow-up childhood cancer survivors and detect late pulmonary toxicity. Patients and methods: Lung function test was performed with spirometry in 26 survivors participated in this study (10 females and 16 males; mean age, 19.4 years at the time of the second follow-up evaluation). The average time periods from treatment until the first and second follow-up evaluation were 4.5 and 10 years, respectively. Results: The authors found 14 patients with pathological pulmonary function tests results at the time of the first follow-up evaluation, from which 7 patients had obstructive, 5 patients had mixed and 2 patients had restrictive abnormalities. However, there were only 6 patients who had abnormal pulmonary function at the time of the second follow-up evaluation (2 patients with obstructive and 4 patients with restrictive pulmonary function tests (p

AB - Introduction: The present investigation was based on a survey in 2005, in which the authors found pulmonary function abnormalities in survivors of childhood cancer, who were treated with anticancer therapy. Aim: The purpose of the present study was to follow-up childhood cancer survivors and detect late pulmonary toxicity. Patients and methods: Lung function test was performed with spirometry in 26 survivors participated in this study (10 females and 16 males; mean age, 19.4 years at the time of the second follow-up evaluation). The average time periods from treatment until the first and second follow-up evaluation were 4.5 and 10 years, respectively. Results: The authors found 14 patients with pathological pulmonary function tests results at the time of the first follow-up evaluation, from which 7 patients had obstructive, 5 patients had mixed and 2 patients had restrictive abnormalities. However, there were only 6 patients who had abnormal pulmonary function at the time of the second follow-up evaluation (2 patients with obstructive and 4 patients with restrictive pulmonary function tests (p

KW - childhood malignancies survivors

KW - lung function test

KW - obstructive changes

UR - http://www.scopus.com/inward/record.url?scp=84874788352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874788352&partnerID=8YFLogxK

U2 - 10.1556/OH.2013.29549

DO - 10.1556/OH.2013.29549

M3 - Article

VL - 154

SP - 345

EP - 350

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 9

ER -